Researchers at Cincinnati Children's Hospital have made a significant breakthrough in the production of human gut organoids, developing a new method that allows for the creation of larger and more functional tissues. Utilizing a 3D-printed confined culture system, the team can now grow organoids that are nearly 10 times larger than previous versions, reaching sizes of up to 8 cm. This innovative approach not only accelerates the growth process, reducing the time needed from 28 days to 14 days, but also enables these organoids to autonomously develop their own nerve cells, a critical advancement for future transplantation applications.

Led by Holly Poling, PhD, and Maxime Mahe, PhD, the research team has demonstrated that these organoids can achieve transplantation maturity twice as quickly while maintaining similar neuromuscular function to native human tissues. The study, published in Nature Biomedical Engineering, highlights the potential of these organoids to patch damaged gastrointestinal organs or restore their functions in patients, particularly benefiting infants and children with organ dysfunction. While further research is necessary before clinical trials can commence, this advancement represents a promising step towards personalized organ therapies.